RENAISSANCE TECHNOLOGIES LLCRENAISSANCE TECHNOLOGIES LLC

Institutional investor · Portfolio as of Q2 2024

SEC EDGAR SourceSEC Filings

Top Holdings3,444 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
NVONVO
ADR

NOVO-NORDISK A/S-SPONS ADR

9.2M$1.3B2.2%$52.08+165.72%
19 qtrssince 2019-Q4
Decreased
0

PALANTIR TECHNOLOGIES INC-A

39.5M$1B1.7%$13.82+83.30%
13 qtrssince 2021-Q2
Decreased
0

NVIDIA CORP

7M$867.5M1.5%$117.15+5.41%
6 qtrssince 2023-Q1
Increased
81

VERTEX PHARMACEUTICALS INC

1.6M$734.2M1.2%$263.50+77.88%
19 qtrssince 2019-Q4
Decreased
0

UNITED THERAPEUTICS CORP

2.2M$692.7M1.2%$95.97+231.91%
19 qtrssince 2019-Q4
Increased
50

VERISIGN INC

3M$538.3M0.9%$191.21-7.82%
19 qtrssince 2019-Q4
Decreased
0

META PLATFORMS INC-CLASS A

1M$527.5M0.9%$345.81+45.09%
12 qtrssince 2021-Q3
Decreased
0

AIRBNB INC-CLASS A

3.4M$515.8M0.9%$122.77+23.51%
13 qtrssince 2021-Q2
Decreased
0

BROADCOM INC

294,115$472.2M0.8%$158.170.00%
1 qtr
New
61

TESLA INC

2.1M$405.9M0.7%$214.16-7.60%
19 qtrssince 2019-Q4
Increased
50

SPROUTS FMRS MKT INC

4.4M$371.3M0.6%$29.87+180.07%
19 qtrssince 2019-Q4
Increased
50

FRANCO-NEVADA CORP /CAD/

3.1M$364.3M0.6%$105.87+10.75%
19 qtrssince 2019-Q4
Decreased
0

APPLE INC

1.7M$362.6M0.6%$204.40+2.07%
16 qtrssince 2020-Q3
Increased
71

GILEAD SCIENCES INC

5.1M$347M0.6%$58.43+12.22%
19 qtrssince 2019-Q4
Increased
51

EXELIXIS INC

15.2M$340.7M0.6%$18.77+19.68%
19 qtrssince 2019-Q4
Increased
44

NEUROCRINE BIOSCIENCES INC

2.5M$339.8M0.6%$116.87+17.80%
19 qtrssince 2019-Q4
Increased
48

CBOE GLOBAL MARKETS INC

1.9M$318.8M0.5%$111.21+51.13%
19 qtrssince 2019-Q4
Decreased
0

CHIPOTLE MEXICAN GRILL INC

5.1M$318.1M0.5%$62.11+0.86%
9 qtrssince 2022-Q2
Increased
70

INCYTE CORP

5.2M$316.3M0.5%$80.95-25.11%
19 qtrssince 2019-Q4
Decreased
0

DOORDASH INC - A

2.8M$303.3M0.5%$92.11+18.10%
13 qtrssince 2021-Q2
Increased
50
$59B
AUM
3,444
Positions
Q2 2024
Filing
Rating · 2.5
Quarterly Portfolio Change
+3%Q1'23$75.4B-8%Q2'23$69.4B-15%Q3'23$58.7B+10%Q4'23$64.6B-2%Q1'24$63.6B-7%Q2'24$59B
Activity profile
$ moved · Q2'24
New8%Increased47%Decreased45%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.5 years
<1Q3%1-4Q5%1-2Y6%2Y+87%

RENAISSANCE TECHNOLOGIES LLC manages $59B across 3444 positions as of Q2 2024. Top holdings: NVO (2.2%), PLTR (1.7%), NVDA (1.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.

Q2 2024 Summary

Active quarter - 481 new positions, 696 exits, 1432 increased. Top move: NVDA (INCREASED, conviction 81). Portfolio: $59.0B across 3444 positions.

Top holdings by portfolio weight

Total AUM$59B
NVO2.22%
PLTR1.70%
NVDA1.47%
VRTX1.25%
UTHR1.18%
VRSN0.91%
META0.89%
ABNB0.87%
AVGO0.80%
TSLA0.69%
Other0.63%

Portfolio allocation by GICS sector

Sectors11
Technology19.03%
Healthcare17.95%
Consumer Cyclical13.59%
Industrials8.46%
Unknown7.89%
Financial Services7.53%
Consumer Defensive6.99%
Communication Services5.68%
Basic Materials4.55%
Energy4.32%
Other4.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record50
Conviction37
Concentration18
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CHGGCHGGCHEGG INC
Q3 2024 Q2 2026+2.7M shares+$1.3M
8Q
CRCTCRCTCRICUT INC
Q3 2024 Q2 2026+500,843 shares+$1.6M
8Q
FVCBFVCBFVCBANKCORP INC
Q3 2024 Q2 2026+290,950 shares+$5.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used